Novacyt S.A. (NCYT.L*): R&D Update | N4 Pharma (N4P.L): Full year results
24 Feb 2021
SP Angel Healthcare Conditions
Sign up to access
Get access to our full offering from over 100 providers
Get access to our full offering from over 100 providers
SP Angel Healthcare Conditions
Novacyt SAS (NCYT:LON), 39.2 | N4 Pharma Plc (N4P:LON), 0.5
- Published:
24 Feb 2021 -
Author:
Vadim Alexandre | Liam Gascoigne-Cohen -
Pages:
4 -
Novacyt S.A. (NCYT.L*): R&D Update | N4 Pharma (N4P.L): Full year results